This site is intended for Healthcare Professionals only.

Professor Colin Melville to retire from GMC next summer

Date:

Share post:

The GMC will start the recruitment process for his successor in September this year

Professor Colin Melville has announced his plan to retire as the Medical Director and Director of Education and Standards at the General Medical Council (GMC) next summer.

Professor Melville joined the GMC in 2017, transitioning from his role as head of Lancaster Medical School.

Before that, he held senior leadership roles at Warwick Medical School, Hull York Medical School, and North Yorkshire East Coast Foundation School.

Professor Melville said: “It has been a difficult decision to leave the GMC, which is a fantastic organisation with so many wonderful colleagues.

“I have had the privilege of overseeing some exciting changes to education and standards, but I believe now is the right for me to step back from a full-time executive role.

“And, of course, I am looking forward to doing some different things and having more time for family and friends.”

A registered doctor and former consultant in intensive care medicine, Professor Melville began his clinical career in 1983.

He was awarded Honorary Fellow of the Academy of Medical Educators in 2018 and became an Honorary Professor in Medical Education at Manchester University. In 2022, he was also appointed Visiting Professor at Anglia Ruskin University.

Professor Melville will retire at the end of June 2025 and the recruitment process for his successor will commence in September, with the position being advertised across the UK through an open campaign.

During his time at the GMC, Professor Melville has overseen the introduction of the Medical Licensing Assessment. He has been instrumental in the regulator’s work to address unfairness in undergraduate and postgraduate medical education, and played a key role in ensuring education and training was maintained during the pandemic.

Charlie Massey, Chief Executive and Registrar of the GMC, said: “While at the GMC Colin has provided strong leadership and strategic direction, and worked tirelessly to oversee an ambitious programme of work that has contributed to real change for the benefit of patients and doctors.

“We are hugely grateful for all that he has achieved, and will be sorry to see him leave.”

 

 

 

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

Exclusive: BGMA chief executive on how CPTPP accession will affect UK medicine manufacturers

CPTPP membership could attract more suppliers to the UK market, thereby reduce drug shortage risks and lower prices...

Community pharmacy ‘overlooked’ during pandemic, NPA tells Covid-19 Inquiry

The NPA asked the Inquiry to consider the resilience of community pharmacy in responding to a future pandemic At...

Work pressures contributing to rise in suicidal thoughts among nurses – RCN report reveals

Workload, bullying and harassment, and a lack of work-life balance cited as key factors contributing to suicidal thoughts...

Pharmacists can use original pack dispensing for NHS prescriptions from January 2025

Community Pharmacy England has advised pharmacists to use professional judgment when considering original pack dispensing as it may...